AEROVATE THERAPEUTICS INC's ticker is AVTE and the CUSIP is 008064107. A total of 57 filers reported holding AEROVATE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,064,000 | -23.6% | 196,038 | -10.4% | 0.62% | -13.3% |
| Q1 2022 | $4,013,000 | +20.4% | 218,913 | -22.6% | 0.71% | +41.8% |
| Q4 2021 | $3,334,000 | -53.4% | 282,764 | -17.2% | 0.50% | -15.8% |
| Q3 2021 | $7,162,000 | -37.3% | 341,367 | -31.7% | 0.60% | -35.5% |
| Q2 2021 | $11,415,000 | – | 500,000 | – | 0.92% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 603,762 | $10,010,000 | 15.59% |
| TCG Crossover Management, LLC | 959,572 | $15,910,000 | 4.77% |
| Atlas Venture Life Science Advisors, LLC | 2,327,909 | $38,597,000 | 4.26% |
| Lynx1 Capital Management LP | 276,447 | $4,583,000 | 4.13% |
| Sofinnova Investments, Inc. | 3,758,686 | $62,319,000 | 3.63% |
| RA Capital Management | 8,263,982 | $137,017,000 | 2.92% |
| Cormorant Asset Management, LP | 2,330,691 | $38,643,000 | 2.70% |
| VR Adviser, LLC | 833,927 | $13,827,000 | 2.13% |
| Ghost Tree Capital, LLC | 150,000 | $2,487,000 | 0.70% |
| Ikarian Capital, LLC | 200,000 | $3,316,000 | 0.66% |